Optimal Anticoagulation for Patients With STEMI Bivalirudin Versus Heparin: What Should Be the Standard of Care in 2017? - George Dangas

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Optimal Anticoagulation for Patients With STEMI Bivalirudin Versus Heparin: What Should Be the Standard of Care in 2017? - George Dangas at CRT 2017.
Loading Simple Education